File Download

There are no files associated with this item.

Supplementary

Conference Paper: Risk factors of adverse surgical outcomes after liver resection for hepatoblastoma - a review of 30 years of experience [Oral presentation]

TitleRisk factors of adverse surgical outcomes after liver resection for hepatoblastoma - a review of 30 years of experience [Oral presentation]
Authors
Issue Date16-Apr-2025
Abstract

Purpose: We reported the surgical outcomes in hepatoblastoma treated over 30 years and analyzed risk factors leading to adverse events.

Methods: This was a retrospective study and children (age < 12 years) receiving liver resection for hepatoblastoma (excluding liver transplant) in two studied centres between 1995 to 2024 were reviewed.  Demographic data, surgical complications and 5-year disease-free survival rate were reported.  Risk factors for 30-day post-operative complications and 5-year tumor recurrence were evaluated by regression analysis.    

Results: This study included 68 patients with 50 (73.5%) of them had PRETEXT III disease.  Nine patients (13.2%) had metastases and 7 (10.3%) experienced tumor rupture prior to surgery. The median age at surgery was 18 months (8 -56 months).  The most frequent type of surgery was extended right hepatectomy (n = 40, 58.8%).  Upfront resection was performed in 8 patients (11.8%). The 30-day post-operative complication rate was 17.6 % (n=12) and 6 patients required second operation.  The median follow up was 12.4 years (range: 1 – 23.5 years) and 5-year disease free survival was 79.4% (n = 54).  

Diving the study cohort into two study periods (1995 to 2009 vs 2010 to 2024), the complication rate and 5-year disease survival rate were 25.0% and 75.0% in the first period; 12.5% and 82.5% in the second period respectively.        

Pre-operative tumor rupture [OR: 1.97 (1.11-2.32), p = 0.048] and operation over 6 hours were risk factors for 30-day post-operative complications [OR: 2.48 (1.91-3.12), p = 0.036].  Presence of distant metastasis was a risk factor for 5-year tumor recurrence [OR: 1.63 (1.05-1.92), p = 0.042]. 

Conclusion: An improvement trend in the surgical outcomes of hepatoblastoma treated in recent years was observed.  Pre-operative tumor rupture and distant metastasis required special attention as they were risk factor for adverse outcomes.  Prolonged operation should be avoided to minimize surgical complications. 


Persistent Identifierhttp://hdl.handle.net/10722/356040

 

DC FieldValueLanguage
dc.contributor.authorChung, PHY-
dc.contributor.authorYeung, F-
dc.contributor.authorWong, KKY-
dc.date.accessioned2025-05-22T00:35:18Z-
dc.date.available2025-05-22T00:35:18Z-
dc.date.issued2025-04-16-
dc.identifier.urihttp://hdl.handle.net/10722/356040-
dc.description.abstract<div><p><strong>Purpose: </strong>We reported the surgical outcomes in hepatoblastoma treated over 30 years and analyzed risk factors leading to adverse events.</p><p><strong>Methods: </strong>This was a retrospective study and children (age < 12 years) receiving liver resection for hepatoblastoma (excluding liver transplant) in two studied centres between 1995 to 2024 were reviewed.  Demographic data, surgical complications and 5-year disease-free survival rate were reported.  Risk factors for 30-day post-operative complications and 5-year tumor recurrence were evaluated by regression analysis.    </p><p><strong>Results: </strong>This study included 68 patients with 50 (73.5%) of them had PRETEXT III disease.  Nine patients (13.2%) had metastases and 7 (10.3%) experienced tumor rupture prior to surgery. The median age at surgery was 18 months (8 -56 months).  The most frequent type of surgery was extended right hepatectomy (n = 40, 58.8%).  Upfront resection was performed in 8 patients (11.8%). The 30-day post-operative complication rate was 17.6 % (n=12) and 6 patients required second operation.  The median follow up was 12.4 years (range: 1 – 23.5 years) and 5-year disease free survival was 79.4% (n = 54).  </p><p>Diving the study cohort into two study periods (1995 to 2009 vs 2010 to 2024), the complication rate and 5-year disease survival rate were 25.0% and 75.0% in the first period; 12.5% and 82.5% in the second period respectively.        </p><p>Pre-operative tumor rupture [OR: 1.97 (1.11-2.32), p = 0.048] and operation over 6 hours were risk factors for 30-day post-operative complications [OR: 2.48 (1.91-3.12), p = 0.036].  Presence of distant metastasis was a risk factor for 5-year tumor recurrence [OR: 1.63 (1.05-1.92), p = 0.042]. </p><p><strong>Conclusion: </strong>An improvement trend in the surgical outcomes of hepatoblastoma treated in recent years was observed.  Pre-operative tumor rupture and distant metastasis required special attention as they were risk factor for adverse outcomes.  Prolonged operation should be avoided to minimize surgical complications. </p></div>-
dc.languageeng-
dc.relation.ispartof58th Annual Meeting of the Pacific Association of Pediatric Surgeons (13/04/2025-17/04/2025, Melbourne, Australia)-
dc.titleRisk factors of adverse surgical outcomes after liver resection for hepatoblastoma - a review of 30 years of experience [Oral presentation]-
dc.typeConference_Paper-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats